Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

 

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
J

Patient With Stage III Lung Adenocarcinoma Treated With Adjuvant Durvalumab: Managing Dermatologic Side Effects

By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Joshua Arbesman, Arthi Venkat, Jung-Min Song, Christian Nasr
By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Joshua Arbesman, Arthi Venkat, Jung-Min Song, Christian Nasr
88 views
March 24, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Common but Complex irAEs
17:03

Dermatologic Side Effects of Cancer Treatment: Cutaneous Reactions A…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

J. Arbesman

185 views
22:57

Endocrine Complications of IO: Pituitary Hormone Profile Should Be A…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

C. Nasr

184 views
15:32

Ophthalmic Side Effects and Local Therapy: Local Control of Uveitis …

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

A. Venkat

12 views
10:08

Patient With Stage III Lung Adenocarcinoma Treated With Adjuvant Dur…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

J. Arbesman, A. Venkat, J. Song, C. Nasr

88 views
13:44

59 y/o Male With Endocrine Complications: Fatigue and Weight Loss Wh…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

J. Arbesman, A. Venkat, J. Song, C. Nasr

19 views
06:37

49 y/o Female & 49 y/o Male With Ophthalmic Complications: More Seri…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

J. Arbesman, A. Venkat, J. Song, C. Nasr

16 views